Search | IOVS | ARVO Journals

Showing 1 – 20 of 119

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Long-term efficacy and Safety of CT-P42 compared to Reference Aflibercept in Diabetic Macular Edema: 52-Week Results from the Phase 3 CT-P42

Paulo-Eduardo Stanga; Sebastian Wolf; Milan Veselovsky; Miroslav Veith; Andras Papp; Shobhana Mange; Lakshikanta Mondal; Sunghyun Kim; Keumyoung Ahn; Suyoung Kim; Dain Son; Hyejin Kang; Hyunjin Lee; David M Brown

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4907.

Artificial Intelligence April 2024

Deep Learning-Based Automated Detection of Retinal Breaks and Detachments on Fundus Photography

PDF

Merlin Christ; Oussama Habra; Killian Monnin; Kevin Vallotton; Raphael Sznitman; Sebastian Wolf; Martin Zinkernagel; Pablo Márquez Neila
TAGS: deep learning, retinal detachment, retinal perforations, fundus photography, learning
Trans. Vis. Sci. Tech.. 2024; 13(4):1. https://doi.org/10.1167/tvst.13.4.1

Retina July 2023

High-Resolution Optical Coherence Tomography in Healthy Individuals Provides Resolution at the Cellular and Subcellular Levels

PDF

Jelena Reche; Andrea B. Stocker; Virgilia Henchoz; Oussama Habra; Pascal Escher; Sebastian Wolf; Martin S. Zinkernagel
TAGS: cell nucleus, fiberoptic examinations anoscopy high resolution, optical coherence tomography, retina
Trans. Vis. Sci. Tech.. 2023; 12(7):12. https://doi.org/10.1167/tvst.12.7.12

Includes: Supplemental Content

ARVO Imaging in the Eye Conference Abstract June 2023

High resolution optical coherence tomography reveals details of regeneration after selective retina therapy

Chantal Dysli; Christian Burri; Simon Salzmann; Boris Povazay; Meier Christoph; Frenz Martin; Martin S. Zinkernagel; Sebastian Wolf

Invest. Ophthalmol. Vis. Sci.. 2023; 64(9):PB0052.

ARVO Annual Meeting Abstract June 2023

Optical Coherence Tomography Guided Selective Retina Therapy: First results from the CENTAURUS study

Chantal Dysli; Christian Burri; Simon Salzmann; Boris Povazay; Christoph Meier; Martin Frenz; Martin Sebastian Zinkernagel; Sebastian Wolf

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1804.

ARVO Annual Meeting Abstract June 2023

Dosimetry of selective retina therapy using optical coherence tomography: first results from the CENTAURUS study

Christian Burri; Chantal Dysli; Simon Salzmann; Boris Povazay; Christoph Meier; Martin Frenz; Martin Sebastian Zinkernagel; Sebastian Wolf

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1799.

ARVO Annual Meeting Abstract June 2023

Detection of outer retinal changes during diurnal rhythm and light adaptation by high resolution optical coherence tomography

Jelena Reche; Andrea B. Stocker; Virgilia Henchoz; Sebastian Wolf; Pascal Escher; Martin Sebastian Zinkernagel

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3348.

ARVO Annual Meeting Abstract June 2023

Compositional and functional features of the gut microbiome in patients with acute onset central serous chorioretinopathy

Martin Sebastian Zinkernagel; Liselotte Berger; Elio Luca Herzog; Sebastian Wolf; Denise Zysset

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3582.

ARVO Annual Meeting Abstract June 2023

Ensemble and Majority-Vote Strategies for Deep-Learning Based Detection of Atrophy-Related Biomarkers in OCT Volumes

Davide Scandella; Mathias Gallardo; Raphael Sznitman; Martin Sebastian Zinkernagel; Sebastian Wolf

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1083.

ARVO Annual Meeting Abstract June 2023

Deep-learning model to localize biological markers on OCT volumes from weak annotations

Javier Gamazo Tejero; Pablo Marquez-Neila; Thomas Kurmann; Mathias Gallardo; Martin Sebastian Zinkernagel; Sebastian Wolf; Raphael Sznitman

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1082.

ARVO Annual Meeting Abstract June 2022

High resolution optical coherence tomography in patients with age related macular degeneration

Oussama Habra; Virgilia Henchoz; Chantal Dysli; Damian Jaggi; Sebastian Wolf; Martin Sebastian Zinkernagel

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1033 – F0280.

ARVO Annual Meeting Abstract June 2022

Challenges in the characterization of the ocular surface microbiome

Elio Herzog; Irene Keller; Sebastian Wolf; Martin Sebastian Zinkernagel; Denise Corinne Zysset-Burri

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1682 – A0512.

ARVO Annual Meeting Abstract June 2022

Compositional features of the gut microbiome in patients with uveitis

Martin Sebastian Zinkernagel; Marion R Munk; Elio Herzog; Sebastian Wolf; Denise Corinne Zysset-Burri

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2218 – A0514.

ARVO Annual Meeting Abstract June 2022

Evaluating an OCT-based Algorithm of Central Subfield Thickness Estimation on AMD and DME patients

Mathias Gallardo; Oussama Habra; Till Meyer zu Westram; Sandro De Zanet; Sebastian Wolf; Raphael Sznitman; Martin Sebastian Zinkernagel

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2993 – F0263.

ARVO Annual Meeting Abstract June 2022

Brolucizumab for treatment of diabetic macular edema (DME): 100-week results from the KESTREL and KITE studies

Charles Clifton Wykoff; Justus G Garweg; Carl Regillo; eric souied; Sebastian Wolf; Dilsher Dhoot; Hansjüergen T Agostini; Andrew Chang; Augustinus Laude; Lidija Kovacic; Lixin Wang; Ying Wang; Emmanuel Bouillaud; David M Brown

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3849.

Immunology and Microbiology August 2021

Understanding the Interactions Between the Ocular Surface Microbiome and the Tear Proteome

PDF

Denise C. Zysset-Burri; Irina Schlegel; Joel-Benjamin Lincke; Damian Jaggi; Irene Keller; Manfred Heller; Sophie Braga Lagache; Sebastian Wolf; Martin S. Zinkernagel
TAGS: microbiome, proteome, comprehension
Invest. Ophthalmol. Vis. Sci.. 2021; 62(10):8. https://doi.org/10.1167/iovs.62.10.8

ARVO Annual Meeting Abstract June 2021

Neovascular age-related macular degeneration (nAMD) treated with intravitreal aflibercept (IVT-AFL) treat-and-extend (T&E): post-hoc analysis of injection intensive (I-I) requirement for patients in the ARIES study

Sebastian Wolf; Frank G Holz; Philip Hykin; Edoardo Midena; Eric H Souied; George Lambrou; Tobias Machewitz; Helmut Allmeier; Paul Mitchell

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):423.

ARVO Annual Meeting Abstract June 2021

Association between visual acuity and intraretinal (IRF) or subretinal (SRF) fluid in patients with neovascular age-related macular degeneration (nAMD) treated with intravitreal aflibercept (IVT-AFL) treat-and-extend (T&E): a post-hoc analysis of the ARIES study

Varun Chaudhary; Frank G Holz; Philip Hykin; Edoardo Midena; Eric H Souied; Sebastian Wolf; Tobias Machewitz; George Lambrou; Paul Mitchell

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):341.

ARVO Annual Meeting Abstract June 2021

Brolucizumab for the treatment of visual impairment due to diabetic macular edema: 52-week results from the KITE and KESTREL studies

David M Brown; Sebastian Wolf; Justus Garweg; Francesco Bandello; Andres Emanuelli; Jose Juan Escobar Barranco; Joao Figueira; Vishali Gupta; Nor Fariza Ngah; Gerald Liew; Raman Tuli; Lixin Wang; Emmanuel Bouillaud; Eric Souied

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1045.

ARVO Annual Meeting Abstract June 2021

Standardization of optical coherence tomography angiography nomenclature in retinal vascular diseases

Meng Tian; Amir H Kashani; Ramin Tadayoni; Jean-Francois Korobelnik; Sebastian Wolf; Francesco Pichi; Marion Ronit Munk

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1874.

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Long-term efficacy and Safety of CT-P42 compared to Reference Aflibercept in Diabetic Macular Edema: 52-Week Results from the Phase 3 CT-P42

Deep Learning-Based Automated Detection of Retinal Breaks and Detachments on Fundus Photography

High-Resolution Optical Coherence Tomography in Healthy Individuals Provides Resolution at the Cellular and Subcellular Levels

High resolution optical coherence tomography reveals details of regeneration after selective retina therapy

Optical Coherence Tomography Guided Selective Retina Therapy: First results from the CENTAURUS study

Dosimetry of selective retina therapy using optical coherence tomography: first results from the CENTAURUS study

Detection of outer retinal changes during diurnal rhythm and light adaptation by high resolution optical coherence tomography

Compositional and functional features of the gut microbiome in patients with acute onset central serous chorioretinopathy

Ensemble and Majority-Vote Strategies for Deep-Learning Based Detection of Atrophy-Related Biomarkers in OCT Volumes

Deep-learning model to localize biological markers on OCT volumes from weak annotations

High resolution optical coherence tomography in patients with age related macular degeneration

Challenges in the characterization of the ocular surface microbiome

Compositional features of the gut microbiome in patients with uveitis

Evaluating an OCT-based Algorithm of Central Subfield Thickness Estimation on AMD and DME patients

Brolucizumab for treatment of diabetic macular edema (DME): 100-week results from the KESTREL and KITE studies

Understanding the Interactions Between the Ocular Surface Microbiome and the Tear Proteome

Neovascular age-related macular degeneration (nAMD) treated with intravitreal aflibercept (IVT-AFL) treat-and-extend (T&E): post-hoc analysis of injection intensive (I-I) requirement for patients in the ARIES study

Association between visual acuity and intraretinal (IRF) or subretinal (SRF) fluid in patients with neovascular age-related macular degeneration (nAMD) treated with intravitreal aflibercept (IVT-AFL) treat-and-extend (T&E): a post-hoc analysis of the ARIES study

Brolucizumab for the treatment of visual impairment due to diabetic macular edema: 52-week results from the KITE and KESTREL studies

Standardization of optical coherence tomography angiography nomenclature in retinal vascular diseases

To View More...

You must be signed into an individual account to use this feature.